11 unchanged sentences
Data for the NASDAQ Composite Index and NASDAQ Biotechnology Index assume reinvestment of dividends, however no dividends have been declared on our common stock to date.
−Removed: $100 investment in stock or index
+Added: $100 investment in stock or index December 31,
+Added: 2020 December 31,
Collegium Pharmaceutical, Inc.
+Added: (COLL) $ 100.00 $ 231.15
NASDAQ Composite Index (IXIC) $ 100.00 $ 180.33
4 unchanged sentences
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
−Removed: The following table sets forth shares of common stock repurchased under our repurchase program authorized by our Board of Directors in January 2024 (the “2024-2025 Repurchase Program”), as well as shares transferred to us from employees in satisfaction of minimum tax withholding obligations associated with the vesting of performance share units and restricted stock units during the three months ended December 31, 2024:
−Removed: Total number of shares purchased
−Removed: Average Price Paid per Share
−Removed: Total number of shares purchased as part of publicly announced plans or programs (1)
−Removed: Maximum approximate dollar value of Shares that may yet be purchased under the plans or programs
+Added: The following table sets forth shares of common stock repurchased under our repurchase program authorized by our Board of Directors in July 2025 (the “2025-2026 Repurchase Program”), as well as shares transferred to us from employees in satisfaction of minimum tax withholding obligations associated with the vesting of performance share units and restricted stock units during the three months ended December 31, 2025:
+Added: Period Total number of shares purchased Average Price Paid
+Added: per Share Total number of shares purchased as part of
+Added: publicly announced plans or programs (1)
+Added: Maximum approximate dollar value of
+Added: Shares that may yet be purchased
+Added: under the plans or programs
(in thousands)
2 unchanged sentences
December 1, 2025 through December 31, 2025 3,590 48.86 — 150,000
−Removed: (1) The 2024-2025 Repurchase Program was announced on January 3, 2024.
−Removed: The 2024-2025 Repurchase Program provides for the repurchase of up to $150.0 million of outstanding shares of our common stock at any time or times through June 30, 2025.
−Removed: The 2024-2025 Repurchase Program did not expire during the three months ended December 31, 2024, nor do we currently plan to terminate the 2024-2025 Repurchase Program prior to expiration.
−Removed: However, there can be no assurance as to the timing or number of shares of any repurchases in the future.
+Added: Total 19,656 (2)
+Added: $ 43.78 — (2)
+Added: (1) The 2025-2026 Repurchase Program was announced on July 1, 2025.
+Added: The 2025-2026 Repurchase Program provided for the repurchase of up to $150.0 million of outstanding shares of our common stock at any time or times through December 31, 2026.
(2) The difference, if any, between the total number of shares purchased and the total number of shares purchased as part of a publicly announced program relates to common stock withheld by us for employees to satisfy their tax withholding obligations arising upon the vesting of performance share units and restricted stock units granted under our Amended and Restated 2014 Stock Incentive Plan.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.